-
1
-
-
84857592537
-
Comparison of rates of reported adverse events associated with i.v. iron products in the United States
-
Bailie GR. Comparison of rates of reported adverse events associated with i.v. iron products in the United States. Am J Health-Syst Pharm. 2012; 69:310-20.
-
(2012)
Am J Health-Syst Pharm
, vol.69
, pp. 310-320
-
-
Bailie, G.R.1
-
2
-
-
0002656565
-
Epidemiology of adverse reaction to non-steroidal anti-inflammatory drugs
-
Weber JC. Epidemiology of adverse reaction to non-steroidal anti-inflammatory drugs. Adv Inflamm Res. 1984; 6:1-7.
-
(1984)
Adv Inflamm Res
, vol.6
, pp. 1-7
-
-
Weber, J.C.1
-
5
-
-
77956481295
-
Use of parenteral iron products and serious anaphylactic-type reactions
-
Wysowski DK, Swartz L, Borders- Hemphill BV et al. Use of parenteral iron products and serious anaphylactic-type reactions. Am J Hematol. 2010; 85:650-6.
-
(2010)
Am J Hematol
, vol.85
, pp. 650-656
-
-
Wysowski, D.K.1
Swartz, L.2
Borders-Hemphill, B.V.3
-
6
-
-
84873075134
-
-
accessed 2012 Apr 12
-
Food and Drug Administration. www.fda.gov/Drugs/ GuidanceComplianceRegulatoryInformation/ Survei llance/AdverseDrugEffects/ default.htm (accessed 2012 Apr 12).
-
-
-
-
7
-
-
84861464954
-
A retrospective comparison of adverse reaction rates with the use of three intravenous iron formulations: A single center experience
-
abstract 1537
-
Okam M, Mandell E. A retrospective comparison of adverse reaction rates with the use of three intravenous iron formulations: a single center experience. Blood. 2010; 116:abstract 1537.
-
(2010)
Blood
, vol.116
-
-
Okam, M.1
Mandell, E.2
-
8
-
-
79955045302
-
Clinical use of intravenous iron: Administration, efficacy and safety
-
Auerbach M, Ballard H. Clinical use of intravenous iron: administration, efficacy and safety. Hematology Am Soc Hematol Educ Program. 2010; 2010:338-47.
-
(2010)
Hematology Am Soc Hematol Educ Program
, vol.2010
, pp. 338-347
-
-
Auerbach, M.1
Ballard, H.2
-
9
-
-
34248592639
-
Is there a difference between the allergic potencies of the iron sucrose and low molecular weight iron dextran?
-
DOI 10.1080/08860220701278208, PII 778552652
-
Sav T, Tokgoz B, Sapahiogly MH et al. Is there a difference between the allergic potencies of the iron sucrose and low molecular weight iron dextran? Ren Fail. 2007; 29:423-6. (Pubitemid 46752324)
-
(2007)
Renal Failure
, vol.29
, Issue.4
, pp. 423-426
-
-
Sav, T.1
Tokgoz, B.2
Sipahioglu, M.H.3
Deveci, M.4
Sari, I.5
Oymak, O.6
Utas, C.7
-
10
-
-
39349083683
-
Tolerability and efficacy of parenteral iron therapy in hemodialysis patients, a comparison of preparations
-
Moniem KA, Bhandari S. Tolerability and efficacy of parenteral iron therapy in hemodialysis patients, a comparison of preparations. Transfus Altern Transfus Med. 2007; 9:37-42.
-
(2007)
Transfus Altern Transfus Med
, vol.9
, pp. 37-42
-
-
Moniem, K.A.1
Bhandari, S.2
-
11
-
-
84873062662
-
FIRST: Head-to-head comparison study (Ferumoxytol compared to IRon Sucrose Trial) of the safety and efficacy of ferumoxytol with iron sucrose for the treatment of iron deficiency anemia (IDA) in patients with chronic kidney disease (CKD)
-
Abstract
-
MacDougall IC, McGlaughlin J, Fortin GS et al. FIRST: head-to-head comparison study (Ferumoxytol compared to IRon Sucrose Trial) of the safety and efficacy of ferumoxytol with iron sucrose for the treatment of iron deficiency anemia (IDA) in patients with chronic kidney disease (CKD). J Am Soc Nephrol. 22:6B2011. Abstract.
-
J Am Soc Nephrol
, vol.22
-
-
MacDougall, I.C.1
McGlaughlin, J.2
Fortin, G.S.3
|